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STATE-OF-THE-ART REVIEW

3D Printing is a Transformative Technology
in Congenital Heart Disease
Shafkat Anwar, MD,a Gautam K. Singh, MD,a Jacob Miller, MD,b Monica Sharma, MS,a Peter Manning, MD,b
Joseph J. Billadello, MD,c Pirooz Eghtesady, MD, PHD,b Pamela K. Woodard, MDd

SUMMARY
Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross successfully ligated for
the ﬁrst time a patent ductus arteriosus in a 7-year-old child. To continue the gains made over the past 80 years,
transformative changes with broad impact are needed in management of congenital heart disease. Three-dimensional
printing is an emerging technology that is fundamentally affecting patient care, research, trainee education, and
interactions among medical teams, patients, and caregivers. This paper ﬁrst reviews key clinical cases where the
technology has affected patient care. It then discusses 3-dimensional printing in trainee education. Thereafter, the role of
this technology in communication with multidisciplinary teams, patients, and caregivers is described. Finally, the
paper reviews translational technologies on the horizon that promise to take this nascent ﬁeld even further.
(J Am Coll Cardiol Basic Trans Science 2018;3:294–312) © 2018 The Authors. Published by Elsevier on behalf of
the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

T

hree-dimensional (3D) printing is an additive

review of cardiac 3D printing focusing primarily on

manufacturing technique with increasing use

acquired structural heart disease. In this paper, we

in health care. As a fabrication technique 3D

review the transformative role of 3D printing in

printing was recently listed by the McKinsey Global

congenital heart disease (CHD) (Central Illustration).

Institute as a “disruptive technology that will transform life, business and the global economy,” with a po-

SCOPE OF CONGENITAL HEART DISEASE

tential economic impact of $200 billion to $600 billion

AND THE NEED FOR TRANSFORMATIVE CARE

between 2013 and 2025 (1). In health care, adoption of
this technology has been a relatively recent phenome-

The prevalence of CHD is approximately 9 in 1,000

non. A recent review found just 2 papers (excluding

live births (5,6). Survival rates vary by disease

case studies and abstracts) in medical publications

complexity, with long-term survival (>20 years) at

before 2000, and that number grew to 189 between

approximately 95% for simple CHD, 90% for moder-

2011 and 2015 (2). Use within cardiology has followed

ate complexity, and 80% for severe, complex CHD (7).

a similar trend, with growth mainly in the past decade

Overall survival rates have steadily increased for even

(3). Vukicevic et al. (4) recently published an excellent

the most complex CHD (8–11), although survival alone
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is not a sufﬁcient outcome measure in the current era.

4. Creation of a 3D ﬁle in a format recognized

Other important metrics include the following: long-

by the 3D printer, usually in the Surface

term morbidity; reintervention rates; length of hos-

Tessellation

pitalization; neurodevelopmental outcomes; cost to

lithography (STL) ﬁle format

the health care system; and patient or caregiver

5. Printing of the physical model

satisfaction. Obtaining the best outcomes requires an
impact at multiple levels, including patients and
caregivers, individual clinicians, the medical team
and the health care system. 3D printing is a disruptive
technology that is affecting each of these key areas in
CHD.
The earliest papers on cardiovascular 3D printing
were published in the early 2000s. Binder et al. (12)
showed feasibility from echocardiographic data in
2000, and Pentacost et al. (13) produced 3D models
replicating cardiac embryology from photomicrographic data in 2001. Soon thereafter, datasets from
computed tomography (CT) or magnetic resonance
imaging (MRI) were used to produce 3D cardiac
models of increasing complexity (14–16), with a
steady rise in publications in the past decade (3).
Figure 1 shows the applications of 3D printing in
medicine, broadly categorized as surgical planning,
education, and manufacturing of custom parts (17).
Given that a 3D model is a replica of a patient’s
anatomy, models may be used for precise pre-surgical
planning and simulation (18–21). Patient-speciﬁc presurgical planning may potentially reduce time spent
in the operating room (OR) and result in fewer complications. In turn, this may lead to shorter postoperative stays, decreased reintervention rates, and
lower health care costs. Given the relatively recent
use of 3D printing in CHD, there are currently no data
supporting these presumed outcomes. Most of the
evidence in published reports is qualitative, through
case reports and series. Emerging reports from other
surgical subspecialties appear promising. Recent data
from craniofacial reports suggest that 3D printing can
improve outcomes, including saving time in the OR
and thus translating to direct cost savings (22,23).

3D PRINTING TECHNOLOGY AND OPTIONS
FOR CARDIOVASCULAR PRINTING
Several recent publications have described the process of medical 3D printing (3,4,24–27), summarized
as these key steps:

Language

or

stereo-

ABBREVIATIONS
AND ACRONYMS
3D = three-dimensional
ACHD = adults with congenital
heart disease

3D printing technologies may be catego-

APC = aortopulmonary

rized as photopolymeric (the use of light to

collaterals

harden a deposited photopolymer), thermo-

ASD = atrial septal defect

plastic (extruding melted thermoplastics in

CHD = congenital heart disease

layers to build up a model), or powder fusion

CT = computed tomography

(a process that fuses ceramic or metal powder

DORV = double outlet right

by using an adhesive or laser beam to create a

ventricle

3D object) (4,24). Printer resolution for

MAPCAs = multiple

higher-end medical-grade printers is in the
order of micrometers, well within the resolution needed to print cardiac structures.
Figure 2 shows these technologies in detail

aortopulmonary collaterals

MRI = magnetic resonance
imaging

OR = operating room
VSD = ventricular septal defect

(28).

Principally, there are 2 main types of cardiac
models: “blood-pool” and “hollow” models. Blood
pool models are solid 3D representations of the blood
pool within

the

cardiac

chambers and vessels

(Figure 3). They are created by segmenting the blood
pool signal, usually from contrast-enhanced CT or
MRI, after which the 3D object is printed. Noncardiovascular structures such as airways or soft tissue may also be included for printing. These models
provide excellent visualization of the great vessels,
extracardiac vasculature, and surrounding structures
such as airways or the esophagus. The drawback of
these types of models is their limited views of intracardiac anatomy.
Hollow models are created by applying a mesh
representing myocardium and vessel walls around
the blood pool signal and then digitally removing the
blood pool signal to show the intracardiac cavities.
The end result is a hollow model showing the intracardiac anatomy in detail. These models are usually
sectioned along a pre-determined cut-plane with 2 or
more sections showing the intracardiac anatomy, as
shown in Figure 4.
A subtype of the hollow models consists of intact
hollow models. These models also show the intracardiac anatomy but are printed intact (i.e., without a
cut-plane), thereby resulting in the most accurate
representation of the heart as it sits in the chest.
When printed in a ﬂexible material, these models

1. Acquisition of a high-resolution 3D imaging dataset

allow

2. Segmentation of the anatomy using specialized

surgical approaches and see the anatomy from a

post-processing software

295

3D Printing in Congenital Heart Disease

cardiothoracic

surgeons

to

use

standard

“surgeon’s perspective,” as they would for the actual

3. Computer-aided design to reﬁne the design, add

case (Figures 5A and 5B). Thus, these models are ideal

cut-planes, or include elements required for model

for surgical simulation, especially when they are

stability

printed in materials that can be cut, can hold suture,

296

Anwar et al.

JACC: BASIC TO TRANSLATIONAL SCIENCE VOL. 3, NO. 2, 2018
APRIL 2018:294–312

3D Printing in Congenital Heart Disease

C E N T R A L IL L U ST R A T I O N Applications of 3D Printing in Congenital Heart Disease

Anwar, S. et al. J Am Coll Cardiol Basic Trans Science. 2018;3(2):294–312.

and can allow engraftment of foreign materials

were selected from a cohort of pediatric and adult

(e.g., patch, cannula).

patients with CHD at our institution who underwent
3D printing. For the complete list of cases, please

APPLICATIONS OF 3D PRINTING IN CHD

refer to Supplemental Table 1. Most of these cases
were printed for surgical planning and simulation;

Several publications have described the use of 3D

others with unique or rare anatomy were printed for

printing in CHD, spanning the spectrum from atrial or

trainee education. The majority of cases had complex

ventricular septal defects (ASDs, VSDs) (29,30) to the

CHD, with a median complexity score of 3 (simple ¼ 1,

most complex cardiac lesions (18,21,25,31–36). Pub-

moderate ¼ 2, great ¼ 3) (37). Most of the cases prin-

lished reports have been summarized in a recent

ted for surgical planning were high-risk surgical

textbook on cardiac 3D printing (24).

candidates, and the median Society of Thoracic

A selection of cases is now reviewed to show the
main applications of 3D printing in CHD. These cases

Surgeons-European Association for Cardio-Thoracic
Surgery mortality category (1 to 5) was 4.
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COMPLEX

INTRACARDIAC

REPAIR.

Three of 1,000 patients born with CHD require

F I G U R E 1 Application of 3D Printing in Medicine

catheter-based or surgical intervention early in life
(38). Outcomes are signiﬁcantly affected by the
complexity of the underlying anatomy and perioperative factors, including cardiopulmonary bypass time,
ischemic time, or circulatory arrest time (39–43). 3D
models allow the visualization and understanding of
complex spatial relationships and enable precise
pre-surgical planning. A common application in CHD
is planning repair of a double-outlet right ventricle
(DORV) requiring a complex intracardiac bafﬂe. This
is typically a high-risk operation, Society of Thoracic
Surgeons-European Association for Cardio-Thoracic
Surgery category 4 (44). Figure 6 shows this application in an 8-month-old (8 kg) patient with a complex
DORV, previously reported by our group (18). The

Most of these applications pertain to cardiology, except for wearable devices, for which

patient had visceroatrial situs inversus, dextrocardia,

the authors did not ﬁnd any cardiac-speciﬁc published reports. Adapted with permission

and a DORV with levomalposed great arteries. The

from VanKoevering et al. (17).

model in Figure 6 demonstrates the key anatomy to
plan a 2-ventricle repair. The patient had a successful
2-ventricle repair consistent with the model-guided

heterotaxy, asplenia syndrome with complex single

pre-surgical

have

ventricle anatomy, and abnormal systemic and

reported the use of 3D printing to plan complex

pulmonary venous connections (Figure 7). He had

intracardiac repairs in patients with multiple VSDs or

previously undergone bilateral bidirectional superior

DORV (30–32,36).

cavopulmonary connections (bilateral Glenn proced-

SURGICAL SIMULATION. The ultimate in pre-surgical

ure) as part of single ventricle palliation. 3D printing

planning using 3D models is one in which a “simu-

was performed to plan his next surgery, a total cav-

lated surgery” is performed, as illustrated by the next

opulmonary connection (aka Fontan). Two 3D models

case. The patient was a 3 1/2-year-old male child with

were printed; 1 multicolor with an axial cut-plane and

plan.

Several

other

groups

F I G U R E 2 3D Printing Technologies

ABS ¼ acrylonitrile butadiene styrene; CJP ¼ color jet printing; Co ¼ cobalt; Cr ¼ chromium; DLP ¼ direct light processing; FDM ¼ fused deposition modeling; FFF ¼ fused
ﬁlament fabrication; HIPS ¼ high impact polystyrene; Ni ¼ nickel; PLA ¼ polylactic acid; PVA ¼ polyvinyl alcohol; SLA ¼ stereolithography apparatus; SLM ¼ selective laser
melting; SLS ¼ selective laser sintering; Ti ¼ titanium; TPE ¼ thermoplastic elastomer; TPU ¼ thermoplastic urethane. Reproduced with permission from Borrello et al. (28).
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F I G U R E 3 Blood Pool Cardiac 3D Model

Source images on the left show the segmented blood pool signal. The model is shown on the right.

a second ﬂexible intact-heart model (no cut-plane) for

simulate “plan A,” “plan B,” or “bailout” scenarios,

surgical simulation. The internal anatomy of both

each with a unique surgical plan. This level of

models was identical. By using the models, detailed

detailed surgical simulation is not feasible with cur-

pre-surgical planning was performed. Speciﬁcally, the

rent standard of care (e.g., 3D volumetric rendering),

models were used to plan placement of the Fontan

and it shows the added value of 3D printed models.

conduit (intracardiac or extracardiac) and to evaluate

Supplemental Video 1 (Figure 7) shows the pre-

its relationship with systemic veins and impact on

surgical planning session for this case with the

pulmonary veins. The model was also used to

cardiothoracic surgeon and cardiologists.

F I G U R E 4 Hollow Cardiac 3D Model Showing Intracardiac Anatomy
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F I G U R E 5 Models for Surgical Planning

(A) Flexible hollow model printed intact with corresponding rigid multicolor model. (B) The “surgeon’s view” through a right atriotomy.
IVC ¼ inferior vena cava; RA ¼ right atrium.

EXTRACARDIAC

SURGERY. 3D

aortopulmonary collaterals (APCs), pulmonary veins,

printing can be a valuable tool to plan extracardiac

and airways that enabled detailed pre-surgical plan-

and vascular surgery in patients with CHD. 3D models

ning. Precise visualization of the complex relation-

are helpful for planning high-risk unifocalization

ships between APCs and surrounding structures

surgery,

case.

enables easier identiﬁcation and surgical manipula-

Figures 8A to 8E show a case of tetralogy of Fallot,

tion during the case, thereby reducing operative time

pulmonary atresia, and MAPCAs in a patient with

and potentially improving the surgical outcome. This

as

AND

illustrated

VASCULAR

by

the

following

22q11 deletion (DiGeorge syndrome), with repair un-

patient underwent a right modiﬁed Blalock-Taussig-

dertaken in 3 stages because of high pre-surgical

Thomas shunt to the right-sided APCs (Figure 8B),

morbidity in this patient. We previously reported

followed by a left modiﬁed Blalock-Taussig-Thomas

the ﬁrst stage of this operation done at 10 months of

shunt (Figure 8D) and, ultimately, successful uni-

age (18). Figure 8 shows all 3 stages. The 3D models

focalization (Figure 8E). 3D printing for pulmonary

show

atresia and MAPCAs offers signiﬁcant beneﬁts over

spatial

relationships

among

the

aorta,

F I G U R E 6 3D Model of Double-Outlet RV Showing Relationships Among Ventricles, VSD, and Outﬂows

The dashed line indicates the potential ventricular septal defect (VSD) bafﬂe pathway to achieve a 2-ventricle repair. Ao ¼ aorta; LA ¼ left
atrium; LV ¼ left ventricle; RV ¼ right ventricle; SVC ¼ superior vena cava; other abbreviations as in Figure 5.
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F I G U R E 7 Simulated Surgery for Complex Total Cavopulmonary Connection Planning Using Flexible, Intact-Heart Model

See Supplemental Video 1. LPA ¼ left pulmonary artery; RPA ¼ right pulmonary artery; RSVC ¼ right superior vena cava; other abbreviations
as in Figures 5 and 6.

current standard of care, also described in prior

device placement and optimizing function in complex

publications (14,21).

CHD, as recently described by Farooqi et al (20) and

VENTRICULAR ASSIST DEVICE AND HEART TRANSPLANT.

transplant planning for recipients with complex CHD,

An endpoint of many patients with CHD is heart

as in the following case. Figures 9A to 9C show a

failure requiring a ventricular assist device or heart

22-year-old male patient with heterotaxy syndrome,

transplant. 3D printing can aid in ventricular assist

unbalanced

Saeed et al. (45). 3D printing can also assist with

atrioventricular

canal,

L-looped
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F I G U R E 8 Staged Repair of Tetralogy of Fallot, Pulmonary Atresia, and MAPCAs

(A) Pre-operative anatomy. (B) Unifocalization of right-sided major aortopulmonary collateral arteries (MAPCAs) and small right pulmonary
artery (PA)–to–right modiﬁed Blalock-Taussig-Thomas shunt. (C) Use of 3D model in the operating room for procedural guidance. (D)
Unifocalization of left-sided major aortopulmonary collateral arteries–to–left modiﬁed Blalock-Taussig-Thomas shunt. (E) Right ventricular
(RV)–to–pulmonary artery conduit placement (green) to unifocalized major aortopulmonary collateral arteries and takedown of bilateral
modiﬁed Blalock-Taussig-Thomas shunts. APC ¼ aortopulmonary collateral; LSCA ¼ left subclavian artery; PTFE ¼ polytetraﬂuoroethylene;
SVC ¼ superior vena cava.
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F I G U R E 9 Heterotaxy, Unbalanced Atrioventricular Canal, Ventricular Inversion, Modiﬁed Fontan

(A) 3D model showing a left ventricle (LV)–to–left superior vena cava (LSVC) conduit and left-sided Glenn procedure that complicates transplantation of a normal donor
heart. (B) Intracardiac anatomy. (C) Intraoperative ﬁndings: explanted heart and a left ventricle–to–left superior vena cava conduit, showing accuracy of the 3D model.
ASD ¼ atrial septal defect; other abbreviations as in Figures 6 and 7.

ventricles (ventricular inversion), and pulmonary

procedure. More recently, a Melody valve was placed

atresia. He had undergone 6 prior sternotomies

in a left ventricular–to–left superior vena cava

including ASD and VSD closure, culminating in a

conduit for conduit stenosis. He presented with se-

unique modiﬁed Fontan procedure with a left ven-

vere protein-losing enteropathy and heart failure.

tricular (pulmonic ventricle)–to–left superior vena

Given the patient’s debilitated state and multiple

cava conduit after thrombosis of his right-sided Glenn

prior sternotomies, he was deemed a very high
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surgical risk for cardiac transplantation. 3D printing

beneﬁt may be feasibility testing for complex or

was performed to plan key components of the trans-

borderline cases, as in the case of this 15-year-old

plant, including thoracic entry, cannulation options,

male patient from our institution with repaired

conduct of bypass, and graft-donor connections. 3D

tetralogy of Fallot who met the criteria for pulmonary

printing for transplant planning has been previously

valve replacement (Figure 12). MRI measurements

described for patients with complex pre-transplant

indicated that his right ventricular outﬂow tract

anatomy (46,47).

dimensions were borderline large for transcatheter

AIRWAY ABNORMALITIES. In CHD cases, the airways

pulmonary valve replacement; thus, a 3D model was

may be involved in the pathophysiology or need to be

made in ﬂexible material to trial pre-stenting as a

accounted for in surgical planning, as demonstrated

precursor to transcatheter pulmonary valve replace-

earlier in the case with tetralogy of Fallot with pul-

ment. The 3D model showed feasibility of the

monary atresia and MAPCAs. In some CHD lesions,

catheter-based strategy, and the procedure was

airways may be directly affected by the cardiovascu-

carried out, with subsequent successful implantation

lar

of a transcatheter pulmonary valve, thereby avoiding

disease.

Examples

include

vascular

rings

(Figure 10A), where aberrant vessels cause airway

surgery.

compression, or compression from dilated pulmonary

Impediments to greater use of 3D models in

arteries in tetralogy of Fallot with absent pulmonary

catheter-based procedures include tissue character-

valve (Figure 10B).

istics of the models that do not respond to balloons

Airway compression or tracheobronchomalacia can

and stents in the same way as native tissue. More-

signiﬁcantly add to morbidity of patients with CHD

over, current models do not reﬂect the physiological

from prolonged ventilator dependence. 3D printing

environment encountered during catheterization,

recently led to a momentous breakthrough in the

with nonpulsatility a major limitation of static

management of these patients with the use of 3D

models. Both these limitations may be overcome with

printed bioresorbable airway splints (48,49). Pilot

future iterations of 3D models, as discussed later in

data from 4 patients are shown in Figure 11. In this

this article.

series 3D printed splints were implanted without
complications and resulted in patency of the airway.
If successful in larger cohorts, this application of 3D
printing will dramatically change the management
and outcomes for these challenging patients. Other
applications of 3D printing in otolaryngology and
airway abnormalities were recently reviewed by
VanKoevering et al. (17).

ADULTS

WITH

CONGENITAL

HEART

DISEASE.

Approximately 85% of children with CHD now survive
into adulthood (60), and adults with CHD (ACHD)
now outnumber children (61). There are an estimated
5 million adult survivors in the United States alone
(62,63). Over the past few decades the proportion of
all deaths in patients with CHD has shifted from infants to the ACHD population (64). Similar to their

CATHETER-BASED INTERVENTIONS. 3D printing has

pediatric counterparts, risk factors that worsen ACHD

been used for catheter-based interventions in CHD,

outcomes include complex anatomy, prior surgeries,

although to a lesser degree compared with cardiotho-

and length of time spent on cardiopulmonary bypass

racic surgery. Some noteworthy applications include

(65–67). Although the challenges involving complex

the following: percutaneous pulmonary valve im-

ACHD are considerable, 3D printing may help in their

plantation, reported as early as 2007 (50); coarctation

management by applications described in prior sec-

procedures (51); and stenting for aortic arch hypoplasia

tions and in recent publications (20,25,26,68,69).

(52). Other reported applications include transcatheter

Representative cases are shown in Figures 13A to 13D,

ASD closure (29), double-lobed left atrial appendage

as previously described (68).

closure (53), caval valve implantation (54), and stenting of Mustard bafﬂe obstruction (55). 3D printing is of

ACCURACY AND QUALITY ASSURANCE IN

particular interest in noncongenital structural heart

CARDIAC 3D PRINTING

disease, including transcatheter mitral and aortic
valve interventions (56–58). Potential beneﬁts in

Accuracy in medical 3D printing is of paramount

interventional cardiology include visualization of

importance, although published reports on this topic

complex anatomy that leads to decreased radiation

are limited. Accuracy is deﬁned by comparison with a

and contrast from ﬂuoroscopy and angiography and

gold standard, and in the case of 3D printed models,

improved procedural outcome. Other beneﬁts may

1 metric of accuracy is comparison with operative

include device development and testing in models

ﬁndings. At our institution, the quality assurance

that replicate abnormal anatomy (59). Finally, a key

process is driven by feedback from our surgical
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F I G U R E 1 0 Airway Abnormalities in Congenital Heart Disease

(A) Vascular ring with posterior compression of trachea by a circumﬂex transverse arch coursing behind the aorta. (B) Severe branch
pulmonary artery dilation in tetralogy of Fallot with absent pulmonary valve with compression and malacia of bilateral mainstem bronchi.
Abbreviations as in Figure 7.
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F I G U R E 1 1 Bioresorbable Airway Splint Manufactured From Polycaprolactone With a Bellowed Design to Promote Expansion and Growth Over Time

Reproduced with permission from Morrison et al. (48).

F I G U R E 1 2 3D Printed Model in a Case of TOF With Borderline Large PA Measurements

Image on the left shows a stent within main pulmonary artery (MPA). Image on the right is an angiogram taken after successful transcatheter
implantation of pulmonary valve. PA ¼ pulmonary artery; TOF ¼ tetralogy of Fallot.
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F I G U R E 1 3 3D Models of Adults With Congenital Heart Disease

(A) A 31-year-old patient with dextrocardia, a double-outlet right ventricle (DORV), and a Fontan procedure. (B) A 19-year-old patient with a bicuspid aortic valve (not
shown) and a severely dilated aortic root and ascending aorta. (C) A 40-year-old patient with a double-outlet right ventricle, 2 VSDs, and classic Glenn and modiﬁed
Mustard procedures (conduit from inferior vena cava [IVC] to left atrium [LA], in green). (D) A 45-year-old patient with a left dominant unbalanced atrioventricular canal,
a double-outlet right ventricle, and right ventricular outﬂow tract obstruction. Abbreviations as in Figures 5 to 8. Reproduced with permission from Anwar et al. (68).

colleagues and ﬁndings in the OR. Between February

of surgery. In infants and young children somatic

2015 and May 2017, the average accuracy score for 21

growth and evolution of the pathophysiology can

3D printed models at our institution was 4 of a

produce relatively large changes to the anatomy as

possible 5 points when the surgeon compared model

time passes; thus, the pre-operative imaging and 3D

anatomy with ﬁndings in the OR. A similar quality

modeling should be performed close to the time of

assurance process was described by Hermsen et al.

anticipated surgery.

(70) for surgical models of hypertrophic obstructive

Besides direct comparison with OR ﬁndings, other

cardiomyopathy. We have found that direct and

metrics of accuracy include comparison with source

ongoing

imaging,

images and user feedback. Olivieri et al. (71) reported

modeling, and surgical teams is essential for main-

communication

among

the

that 3D printed models from echocardiographic data

taining high levels of accuracy. In addition, model

were comparable in measurements of VSDs when

accuracy may be diminished if there is a signiﬁcant

compared with source images. Yoo et al. (72) reported

delay between acquisition of source images and time

data from 50 surgeons after undergoing a Hands-on
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F I G U R E 1 4 Patient and Model Doppler Comparisons

Doppler proﬁle of a patient’s echocardiogram on the left, compared with the Doppler image from the 3D printed model on the right. Arrows
point towards the aortic valve from the patient’s echocardiogram (left) and model (right). Adapted with permission from Vukicevic et al. (4).

Surgical Training course using 3D models. The ma-

established practice in neurosurgery (73,74) and

jority of cardiothoracic surgeons reported that the 3D

otolaryngology (17), with more recent application in

models were of “excellent” or “good” quality for

cardiology (75–78). Although medical training has long

surgical simulation (72). Finally, accuracy of 3D

followed the practice of “see 1, do 1, teach 1,” use of 3D

models may be judged in terms of their ability to

models in education represents a paradigm shift from

recreate native physiology, not just anatomy. The

an apprenticeship model to a simulator-based learning

innovative work of Vukicevic et al. (4) has shown the

method

ability to recreate “hemodynamics” of abnormal

training (79,80). 3D models in CHD can reduce the

aortic valves in 3D models, with Doppler character-

learning curve for cardiac trainees in 3 key areas:

istics nearly identical to those of the patient’s own
diseased valve (Figure 14).

3D PRINTING FOR TRAINEE EDUCATION AND
SURGICAL SIMULATION

that

complements

traditional

mentored

1. Understanding complex 3D anatomy
2. High-ﬁdelity simulation experiences
3. Exposure to rare cases
As a tool for surgical simulation, 3D printing has
been applied toward septal myectomy for hypertro-

Another arena where 3D printing can bring about

phic obstructive cardiomyopathy (70), vascular pro-

transformative change is in the education and training

cedures

of the next generation of physicians. This is an

procedures, as described by Yoo et al. (72) (Figure 15).

(76,77,81),

and

complex

congenital
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F I G U R E 1 5 Simulated Arterial Switch Operation From a

Hands-on Surgical Training Course for Cardiothoracic
Surgeons

patient outcomes (86–88). 3D models provide clarity,
and they are cornerstones around which multiple
subspecialists can gather to discuss the pathological
condition, surgical plan, anticipated outcomes, and
perioperative care. In so doing, they may reduce
medical errors, a postulate that deserves further
investigation.
In addition to facilitating communication among
medical team members, 3D models enable better
communication between the medical team and
patients or their caregivers (51,89,90). The models can
help the patient or caregiver better understand the
disease process, risks, beneﬁts, and alternatives.
Anecdotally, our institutional practice is to counsel
patients and families by using 3D models if a model
has been printed for a case. Eleven caregivers who
completed a questionnaire for cardiac models between 2014 and 2017 reported that the models were
“very helpful” (score 5 of 5) to improve understanding
of the anatomy. Similarly, Biglino et al. (75) reported
that 3D models could help improve the family’s

Reproduced with permission from Yoo et al. (72). See

experience with medical care when models were used

Supplemental Video 2. LCA ¼ left coronary artery; other

for counseling. More data are needed on the poten-

abbreviations as in Figures 5 and 6.

tially powerful impact of 3D printing in patient and
family education and shared decision making.

In addition to allowing practice on highly accurate
simulators, the 3D models expose trainees to patho-

ADVANCED APPLICATIONS AND
FUTURE DIRECTIONS

logical features they may rarely encounter. This shifts
the practice of surgery from an “opportunity-based”
(26) to a “curriculum-based” experience. For experienced practitioners, models may be used for lifelong
learning, for maintenance of certiﬁcation, or for
practice before challenging cases. Thus, a repository of
3D printed cardiovascular models with the spectrum
of CHD would be an ideal educational resource (82,83).
The 3D print Heart Library at the National Institutes of
Health (84) is a good example of this concept. Electronic 3D models may supplement traditional learning
methods, and an example is shown in Supplemental
Video 2 (Figure 15). Finally, virtual reality displays
may be used as complementary platforms to interact
with electronic 3D models, with several robust options
currently available (25,85).

3D printing is rapidly evolving in medicine, with
technical improvements in printers and software
fueling new and exciting applications in patient care,
innovation, and research. In cardiovascular medicine,
a major limitation is high-resolution printing of
structures currently not well resolved by CT or MRI,
such as atrioventricular valves (91) or the atrial
septum. 3D printing from 3D echocardiography could
potentially overcome these limitations, with some
promising early results (92–96). 3D printing from
angiographic

imaging

could

expand

options,

currently largely unexplored (97). The next evolution
in 3D printing would be “multimodality” printing,
with a model created by combining key elements of
the anatomy from different imaging modalities. True
co-registration of a highly accurate dataset is a tech-

3D PRINTING TO FACILITATE

nical challenge, and there are some early feasibility

COMMUNICATION WITHIN THE

data (98,99).

MEDICAL TEAM AND FOR COUNSELING
PATIENTS AND FAMILIES

In addition to advances in 3D dataset acquisition
and post-processing, the next major step forward in
3D printing will likely be driven by improvements in

Cardiac surgery and perioperative care are conducted

printer technology and print materials. “Tissue

in a multidisciplinary setting requiring highly skilled

mimicking” materials currently under development

and specialized teams. Communication among spe-

(100,101) would enable the creation of more life-like

cialists is essential for avoiding errors and optimizing

models that replicate the patient’s unique anatomy
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and physiology. Currently there are highly accurate

may be lowered by printing off-site through commer-

noninvasive methods to assess cardiac function and

cial vendors, although with inherent trade-offs in

blood ﬂow (102), including methods to assess 3D in-

long-term costs and turn-around time. These are

formation over the cardiac cycle, thereby providing

evolving issues, and the ultimate viability of medical

“4D” function and ﬂow. These multivariate datasets

3D printing will in large part depend on the impact

could be integrated into 3D models to build holistic

it has on improving patient care.

models to advance our understanding of cardiac disease. As 3D models achieve more realistic states, they
may be used to study pathophysiology, predict longterm outcomes, and choose optimal treatment plans
or surgical repairs (58,103–107). Recent studies have
analyzed blood ﬂow in deformable models (108,109),
including ﬂow characteristics in patients with hypoplastic left heart syndrome following Norwood arch
reconstruction (75,110).
Finally, bioprinting offers the potential to make
the leap from printing “life-like” to living tissue itself.
This revolutionary technology is in its infancy; however, several techniques now exist that can deposit
bioinks in precise locations to build up complex tissue
constructs (111). Bioprinting has been applied to print
anatomically shaped cartilage structures (112), skin
(113,114), implants for bone growth (115), and even a
3D printed “bionic ear” (116). Within cardiology, re-

CONCLUSIONS
3D printing is a transformative technology that is
affecting key aspects of CHD care. As a planning and
simulation tool, if offers the promise of more precise
surgery with fewer complications. For training, 3D
models can reduce the learning curve and increase
opportunities for procedural practice. The models can
facilitate communication among multidisciplinary
teams, thus potentially reducing medical errors. They
can increase engagement of patients and families,
thereby enhancing shared decision making. Finally,
3D models can lead to medical breakthroughs by
enabling basic science, translational, and clinical investigations. More data are needed to quantify these
potential beneﬁts from 3D printing, and the early
experience is promising.

searchers have reported techniques to print vascula-
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